GL1X · GenesisL1 explorer

Research workbench

Complex of human CYP3A4 with a desoxyritonavir analog

Analyse Complex of human CYP3A4 with a desoxyritonavir analog in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4K9U
Type
protein
Length
450 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytochrome P450 3A4
EC
1.14.13.-, 1.14.13.157, 1.14.13.32, 1.14.13.67, 1.14.13.97
UniProt
P08684
Ligands
5AW, HEM
Pockets
5 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACytochrome P450 3A4 (EC 1.14.13.-, 1.14.13.157, 1.14.13.32, 1.14.13.67, 1.14.13.97)protein45053% helix, 9% strandP08684

Ligands and binding sites

  • 5AW · N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-N-[(2S,5S)-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-D-valinamide · ligand · 2 copies · chains A
  • HEM · Protoporphyrin IX containing Fe · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111730.820.8391HEM, 5AW
22330.510.7530empty
31350.430.7626empty
41380.430.7621empty
5680.330.7615empty

Compared structures

  • 4K9U · Complex of human CYP3A4 with a desoxyritonavir analog · the same entry in another collection · chain A against A, TM-score 1.00
  • P08684 · AlphaFold monomer V2.0 prediction for cytochrome P450 3A4 (P08684) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.